期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles 被引量:9
1
作者 Li-Cheng Dai Xing Yao +5 位作者 Xiang Wang Shu-Qiong Niu Lin-Fu Zhou Fang-Fang Fu shui-xin yang Jin-Liang Ping 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第16期1966-1972,共7页
AIM:To synthesize antisense oligonucleotides (ASODNs) of midkine (MK), package the ASODNs with nanoparticles, and to inhibit hepatocellular carcinoma (HCC) growth using these nanoparticles.METHODS: HepG2 cell prolifer... AIM:To synthesize antisense oligonucleotides (ASODNs) of midkine (MK), package the ASODNs with nanoparticles, and to inhibit hepatocellular carcinoma (HCC) growth using these nanoparticles.METHODS: HepG2 cell proliferation was analyzed in vitro using the 3-(4,5-dimethythiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium, inner salt assay. The in vivo activity of nanoparticles delivering the MK-ASODNs was analyzed by histopathological and immunohistochemical staining and quantitative real time polymerase chain reaction (PCR). RESULTS: The in vitro proliferation of HepG2 cells was signif icantly inhibited by the nanoparticles packaged with MK-ASODNs (NANO-ASODNs). Furthermore, the NANO- ASODNs signif icantly inhibited the growth of HCC in the mouse model. CONCLUSION: NANO-ASODNs can significantly suppress the growth of HCC in vitro and in vivo. 展开更多
关键词 MIDKINE NANOPARTICLES Hepatocellular carcinoma INHIBITION Drug delivery
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部